FIELD: medicine. SUBSTANCE: method involves injection of heparin in concentration of 100 mg per kg into peritoneum of laboratory mice and detection of maximal suppression of number of circulated NEUTROPHIL granulocytes as well as their main functions (reception, phagocytic function, function of microbicide system) after one hour. EFFECT: possibility to test correction influence of immunity modulators with respect to NEUTROPHIL granulocytes. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF MODELLING IMMUNODEFICIENT STATE BY NEUTROPHIL GRANULOCYTE SYSTEM | 1995 |
|
RU2118850C1 |
| METHOD OF SIMULATING IMMUNODEFICIENT CONDITION IN EXPERIMENTAL ANIMALS | 1996 |
|
RU2123702C1 |
| AGENT FOR CORRECTION OF NEUTROPHIL GRANULOCYTE FAILURE | 1995 |
|
RU2112513C1 |
| METHOD FOR DETERMINING THE ROSETTE FORMING NEUTROPHIL REACTION | 0 |
|
SU1758556A1 |
| METHOD OF PREDICTING PURULENT-SEPTIC DISEASES OF CHILDREN | 0 |
|
SU1597664A1 |
| METHOD FOR SECONDARY IMMUNODEFICIENCY SIMULATION FOR SMALL LABORATORY ANIMALS | 2016 |
|
RU2644539C2 |
| AGENT INTENSIFYING ACTION OF BIOLOGICALLY ACTIVE SUBSTANCES AND DRUGS | 2009 |
|
RU2421239C1 |
| 4-HYDROXY-3-[N-(PHENACYL)BENZYLAMINO]-N-BENZYLBUTAMIDE HYDROBROMIC SALT SHOWING LOCAL ANESTHETIZING ACTIVITY | 1989 |
|
SU1713242A1 |
| METHOD OF ALIMENTARY ALLERGY TREATMENT | 1991 |
|
RU2017492C1 |
| AGENT ELICITING ANTICOAGULATING AND IMMUNOTROPIC EFFECT | 2002 |
|
RU2247574C2 |
